Pharmatica

The Chain Reaction

Science EN ↓ 3 epizód

Chain Reaction covers pharmaceutical manufacturing, bioprocessing, scale-up strategy, CDMO partnerships, cold chain logistics, quality assurance, validation, smart factories, supply chain resilience and the operational decisions that move therapies from production to patients.

Mindenképp látogasd meg a podcast oldalát, és támogasd a készítőjét: pharmatica.io

Szerző

Pharmatica

Kategória

Science

A podcast weboldala

pharmatica.io

Legutóbbi epizód

2026. júl. 8.

Hol hallgathatod?

Podcastok az alkalmazásban Replaio Radio Hamarosan

A podcastok hamarosan megérkeznek az alkalmazásba. Telepítsd most, és láss elsőként egy teljesen új megközelítést a podcastokhoz

Telepítsd ingyen Android közel 10 M letöltés · 4,8-as értékelés iOS hamarosan

Epizódok

How AI Is Reshaping Data Integrity in Pharma Manufacturing 08.07.2026 44:01

With artificial intelligence (AI) now in pharmaceutical manufacturing, regulators have begun to pay close attention. In fact, oftentimes, they move forward without waiting for adequate guidelines. In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io...

The Role of Regulatory Leadership in Healthcare 09.06.2026 21:18

Approval alone does not guarantee patient access, and for pharmaceutical leaders, that gap is becoming one of the industry's most pressing challenges. Regulatory strategy can no longer function as a back-end compliance exercise. It now plays a central role in determining how quickly therapies reach patients, how organisations scale across markets, and whether innovation delivers measurable healthc...

Rebuilding Healthcare Supply Chains in Africa: Lessons from COVID-19 and the Road Ahead 09.06.2026 23:57

Healthcare systems around the world are facing growing pressure from supply chain disruption, rising costs, regulatory complexity, and persistent medicine shortages. The COVID-19 pandemic exposed just how vulnerable global pharmaceutical and healthcare networks can be, forcing industry leaders to rethink resilience, localisation, and long-term sustainability. At the same time, emerging technologie...